Browsing Tag
ZORYVE
3 posts
Toddlers get a breakthrough eczema treatment as FDA clears Arcutis’ ZORYVE cream 0.05%
Find out how Arcutis’ FDA-approved ZORYVE 0.05% cream is reshaping the pediatric eczema market and investor confidence in 2025.
FDA approves Arcutis Biotherapeutics’ ZORYVE for pediatric and adult atopic dermatitis
In a significant development for the treatment of atopic dermatitis (AD), Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) announced the…
Arcutis Biotherapeutics gets ZORYVE FDA approval for seborrheic dermatitis
Arcutis Biotherapeutics, Inc., a pioneer in immuno-dermatology, has announced the U.S. Food and Drug Administration’s (FDA) approval of…